Images from a positron emission tomography (PET) scanner show the location of the cancer. This type of drug appears to be the best diagnostic tool for staging prostate cancer and determining whether it has metastasized, says Dresser, the chief of nuclear medicine at the Truman VA.
The Million Veteran Program continues to make strides toward improving Veteran health care, thanks to more than 1 million participants.
VA’s National Oncology Program is working to better deliver equitable cancer care through new initiatives and programs.
The comprehensive Cleland-Dole Act will provide greater access to mental health, honor for aging Veterans, self-scheduling and innovative research.
I’m involved in prostate cancer basic research and new drug development. Prostate cancer is the most common non-skin cancer in Veterans. About 35,000 Veterans with prostate cancer receive treatment in the VA system.
The PACT Act expands access to VA disability compensation for Vietnam Veterans.
Lynch Syndrome is a collection of genetic mutations that can indicate an increased risk for colorectal cancer. Lifetime risk of colorectal cancer with this signature ranges from 10% to 80%.
The Million Veteran Program looks to study military exposures specific to different eras of military service.
Air Force Veteran participating in phase 3 clinical trial at Harry S Truman VA aimed at improving the ability to stage prostate cancer.
VA has taken on the challenge of the Cancer Moonshot, leading the charge with best-in-class cancer care for our Veterans across the country.
PACT ACT is the most significant expansion of benefits and services for toxin-exposed Veterans in more than 30 years. Cancer Moonshot helps foster a cancer research community within VA.
Prostate cancer is the most commonly diagnosed cancer among Veterans in VA. It accounts for nearly a third of cancer diagnoses. Prostate cancer is often found early and cured with treatments such as surgery or radiation. But some patients’ cancer spreads and becomes life-threatening.